Table 1. Patient demographics and clinical outcomes.

Characteristic	T-ICL	T-Artisan	P-value (CI)a
(a) Baseline demographic and clinical characteristics of the T-ICL and T-Artisan groups.
Number of eyes (OD/OS)	30 (16/14)	31 (13/18)
Mean age: years (range)	28.6 (21–38)	29.0 (21–46)
Gender
Male	13	8
Female	17	13
LogMAR UCVA	1.67±0.33	1.65±0.52	0.940 (−0.231∼0.272)
LogMAR BSCVA	0.02±0.05	0.03±0.06	0.732 (−0.021∼0.272)
Mean spherical equivalent (range)	−9.80±2.49 (−14.63 to −5.5)	−10.04±3.48 (−11.75 to −2.13)	0.212 (−1.792∼1.317)
Mean manifest cylinder power (range)	−2.47±0.66 (−3.5 to −1.75)	−2.62±0.54 (−4.25 to −2.0)	0.588 (−0.462∼0.154)

	Pre-op.	Post-op. 1 month	Post-op. 3 months	Post-op. 6 months
(b) Changes in visual acuity and refractive error in the T-ICL and T-Artisan groups.
LogMAR UCVA
T-ICL	1.67±0.33	0.02±0.11	−0.04±0.09	−0.04±0.08
T-Artisan	1.65±0.52	0.13±0.15	0.06±0.10	0.03±0.06
P-valuea	0.940	<0.001	0.026	0.021
LogMAR BSCVA
T-ICL	0.02±0.05	0.02±0.08	−0.07±0.04	−0.09±0.03
T-Artisan	0.03±0.06	0.03±0.08	−0.03±0.06	−0.04±0.06
P-valuea	0.732	0.112	0.136	0.277
SE
T-ICL	−9.80±2.49	−0.37±0.37	−0.22±0.32	−0.09±0.38
T-Artisan	−10.04±3.48	−1.00±0.62	−0.75±0.62	−0.65±0.50
P-valuea	0.212	0.20	0.266	0.245
Manifest cylinder power
T-ICL	−2.47±0.66	−0.88±0.38	−0.74±0.36	−0.44±0.44
T-Artisan	−2.62±0.54	−2.75±1.97	−1.17±1.29	−0.75±0.64
P-valuea	0.588	<0.001	0.162	0.330

Abbreviations: CI, 95% confidence interval; LogMAR BSCVA, logarithm of the minimum angle of resolution of best spectacle-corrected visual acuity; LogMAR UCVA, logarithm of the minimum angle of resolution of uncorrected visual acuity; op., operation; T-Artisan, iris-fixated toric phakic intraocular lens; T-ICL, Toric implantable collamer lens.

^aMixed model allowing estimates of repeated measures.